Viatris (VTRS) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Viatris (VTRS) is Neutral.

The composite score behind that read is +0.08, weighing +0.24 of bullish evidence against -0.36 bearish.

Viatris last closed at $17.64, +1.15% on the session.

Against the IVW growth benchmark the position is +0.35% over the forecast window.

The read is built from 15 underlying insights — 8 bullish and 7 bearish.

Agreement across those insights is 47%.

2 graded predictions for VTRS so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Viatris in the 37th percentile on return on equity, where 100 is best.

Viatris is classified under Health Care / Pharmaceuticals, with a market capitalisation of $20.03B.

StockMap tracks Viatris as the 15th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Viatris ranks 44th of 151 in the group, against a group median of -0.08.